NR1H4 and metabolic dysfunction-associated steatotic liver disease: The H-HS and C-HS group cholesterol steady equilibrium may be destroyed, and further promotion of non-alcoholic fatty liver disease (NAFLD) by influencing the FXR-FGF15/19 signaling pathway (37, 38) requires further detection.